Spirovant Continues Rapid Growth with New Headquarters and Expanded Leadership
Accomplished Leaders in Gene Therapy Join Team PHILADELPHIA, PA, January 26, 2021 – Spirovant Sciences, a gene therapy company developing treatments and cures for respiratory diseases including cystic fibrosis, today announced the leasing of its new, expanded headquarters and laboratories in the robust gene and cell therapy epicenter of Philadelphia’s University City in Wexford Science + […]